December 19, 2016 / 12:17 PM / 8 months ago

BRIEF-Spring Bank and Arbutus Biopharma announce preclinical collaboration in study of chronic hepatitis B

Dec 19 (Reuters) - Arbutus Biopharma Corp

* Spring bank pharma - to collaborate preclinical studies in chronic hepatitis b involving co-administration of co's sb 9200, arbutus biopharma's ab-423

* Spring bank and arbutus biopharma announce preclinical collaboration in study of chronic hepatitis b Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below